Public demo
Aggregate findings come from the real MIMIC-IV cohort run. Patient-level fields are redacted per the PhysioNet DUA. Inference was performed locally during the original run. Candidate table is capped at 200 rows
*
for this public demo.
Gemma
4
Science
Trials
›
Loading…
Jobs
Methodology
Gemma
4
Science
Trials
›
Loading…
Jobs
Methodology
Gemma
4
Science
Trials
›
PARADIGM-HF
›
demo_131
Jobs
Methodology
Patient demo_131
note candidate
— · —
4
pass
3
fail
2
unknown
9
pending
Incl1
screening visit
PENDING
Informed consent
Incl2a
structured
PASS
Heart failure diagnosis (ICD I50 / 428)
Incl2b
structured
PASS
Adult ≥ 18
Incl3a
llm
FAIL
NYHA functional class II–IV
Incl3b
llm
UNKNOWN
LVEF ≤ 35%
Incl3c
llm
PASS
NT-proBNP ≥ 400 pg/mL
Incl4
llm
UNKNOWN
ACEi/ARB therapy ≥ 4 weeks, tolerated
Incl5
llm
FAIL
β-blocker therapy ≥ 4 weeks, tolerated
Excl1
screening visit
PENDING
Other investigational drugs within 30 days / 5 half-lives
Excl2
screening visit
PENDING
ACEi or ARB hypersensitivity
Excl3
screening visit
PENDING
Previous intolerance at target dose
Excl4a
structured
PASS
Documented angioedema (ICD T78.3 / 995.1)
Excl4b
llm
FAIL
History of angioedema in the chart
Excl5
screening visit
PENDING
Concurrent ACEi + ARB
Excl6
screening visit
PENDING
Currently acute decompensated heart failure
Excl7
screening visit
PENDING
Symptomatic hypotension and/or SBP < 100 mmHg
Excl8
screening visit
PENDING
eGFR < 30 mL/min/1.73 m²
Excl9
screening visit
PENDING
Serum K+ > 5.2 mmol/L
Admissions
1 on file · latest first
▸
Admission #1
Most recent
· █████████
█████████████████████████████████
Incl 2a · PASS
Incl 2b · PASS
Incl 3a · FAIL
Incl 3b · UNKNOWN
Incl 3c · PASS
Incl 4 · UNKNOWN
Incl 5 · FAIL
Excl 4a · PASS
Excl 4b · FAIL
Refer to screening visit to verify the manual criterion.
Defer
Refer to screening visit